Skip to main content
Log in

Vascularity demonstrated by doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background

Vascularity is an important determinant of a tumour's ability to grow and disseminate. Breast tumour vascularity can be determined with doppler ultrasound (US) and by counting the vessels microscopically (microvascular density — MVD). The biologic characteristics of tumours based on their vascularity have not been extensively studied.

Method

Preoperative US was performed on 207 patients with invasive ductal breast carcinomas (IDC). MVD was assessed immunohistochemically using polyclonal antisera against factor VIII and the proliferation rate was measured with Ki-67 polyclonal antisera. Histologic tumour characteristics and oestrogen receptor (ER) status were determined. Thermography was performed on 174 of the patients.

Results

Twenty-five percent of IDC demonstrated US-vascularity. US-vascular tumours were more likely to be node positive, and had a higher mitotic rate than avascular cancers. US-vascularity was more common in tumours with MVD greater than 80 vessels/250x field than those with fewer vessels. The proliferation rate, histologic grade III, and nuclear grade III were higher and ER positivity lower, but the differences were not statistically significant. US-vascular cancers were associated with significantly more thermographic abnormalities. The cancer recurrence rate at three years was higher in patients with vascular cancers although the difference was not statistically significant.

Conclusion

US appears to be a simple, non-invasive method of identifying vascular cancers associated with factors indicating a poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Folkman J: Tumour angiogenesis.In: Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. WB Saunders, pp 206–232, 1995

  2. Gasparini G, Harris AL: Clinical importance of the determination of tumour angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13:765–782, 1995

    PubMed  Google Scholar 

  3. Adler DD, Carson PL, Rubin JM, Quinn-Reid D: Dopplerultrasound color flow imaging in the study of breast cancer: Preliminary findings. Ultrasound Med Biol 16:553–559, 1990

    PubMed  Google Scholar 

  4. Bergonzi M, Calliada F, Passamonti C, Campani R, Bottinelli O, Genovese E, Bozzetti E, Corsi G, Leoni P, Bozzini A: Color doppler in the echographic evaluation of breast nodules. Radiol Med 79:178–181, 1990

    Google Scholar 

  5. Cosgrove DO, Bamber JC, Davey JB, McKinna JA, Sinnett HD: Color doppler signals from breast tumors. Work in progress. Radiology 176:175–180, 1990

    PubMed  Google Scholar 

  6. Dixon JM, Walsh J, Paterson D, Chetty U: Colour doppler ultrasonography studies of benign and malignant breast lesions. Br J Surg 79:259–260, 1992

    PubMed  Google Scholar 

  7. Weidner N, Semple JP, Welch WR, Folkman J: Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 324:1–8, 1991

    Google Scholar 

  8. Gerdes J, Schwab U, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20, 1983

    PubMed  Google Scholar 

  9. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal carcinomas. Cancer 64: 1914–1921, 1989

    PubMed  Google Scholar 

  10. Elston CW, Ellis IO: Pathologic prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: Experience from a large study with long-term follow-up. Histopathol 19:403–410, 1991

    PubMed  Google Scholar 

  11. Hsu SM, Raine L: The use of avidin biotin-peroxidase complex (ABC) in diagnostic and research pathology.In: DeLessis RA (ed) Advances in Immunohistochemistry in Diagnostic and Research Pathology. Masson, New York, 1984, pp 31–42

    Google Scholar 

  12. Barbareschi M, Girlando S, Mauri FM, Forti S, Eccher C, Mauri FA, Tongi R, Palma PD, Doglion C: Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies and breast carcinomas. Amer J Clin Pathol 102:171–175, 1994

    Google Scholar 

  13. Dawson AE, Norton JA, Weinberg DS: Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Amer J Pathol 136:1115–1124, 1993

    Google Scholar 

  14. Chaney JV: Comparison of manual counting with image analysis using proliferating cell nuclear antigen to estimate S-phase in infiltrating ductal carcinoma of the breast. Amer J Clin Pathol 98:347, 1993

    Google Scholar 

  15. Zafrani B, Leroyer A, Fourquet A, Laurent M, Trophilme D, Validire P, Sastre-Garau X: Mammographically detected ductal carcinoma in situ of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and erbB-2 proteins and proliferative activity. Sem in Diag Pathol 11: 208–214, 1994

    Google Scholar 

  16. Hanna WM, Kahn HJ, Chapman JAW: The correlation of Ki67 growth factor and ERICA in breast cancer. Mod Pathol 5:220–223, 1992

    PubMed  Google Scholar 

  17. Sterns EE, Zee B: Thermography as a predictor of prognosis in cancer of the breast. Cancer 67:1678–1680, 1991

    PubMed  Google Scholar 

  18. Hsieh C-Y, Wu C-C, Chen T-M, Chen C-A, Chen C-L, Wang J-F, Chang C-F, Hsieh F-J: Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color doppler ultrasound. Cancer 75:2518–2522, 1995

    PubMed  Google Scholar 

  19. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761, 1992

    PubMed  Google Scholar 

  20. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL: Tumour angiogenesis in node-negative breast carcinomas — relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109–116, 1994

    PubMed  Google Scholar 

  21. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza: Tumour microvessel density, p53 expression, Tumour size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncology 12:454–466, 1994

    Google Scholar 

  22. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120–1124, 1992

    PubMed  Google Scholar 

  23. Sahin AA, Sneige N, Ordonez GN, Singletary E, Ayala A: Tumour angiogenesis detected by Ulex europaeus agglutinin 1 lectin (UEA 1) and factor VIII immunostaining in node-negative breast carcinoma (NNBC) treated by mastectomy: prediction of tumour recurrence. Mod Pathol 6:19a, 1993

    Google Scholar 

  24. Sneige N, Singletary E, Sahin A, El-Naggar A: Multiparametric analysis of potential prognostic factors in node negative breast cancer patients. Mod Pathol 5:18a, 1992

    Google Scholar 

  25. Toi M, Kashitani J, Tominaga T: Tumour angiogenesis is an independent prognostic indicator in primary breast carcinoma. Internat J Cancer 55:371–374, 1993

    Google Scholar 

  26. Costello A, McCann A, Carney D, Dervan P: Lack of prognostic significance of microvessel density in lymph node negative breast carcinoma. Ann Meeting Abs Internat Acad Pathol, 1995

  27. Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JR: Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1:223–229, 1992

    PubMed  Google Scholar 

  28. Kaldjian EP, Jin L, Davenport RD, Lloyd RV: Immunohistochemical analysis of hormone receptors, Tumour vascularity, and proliferative activity in paraffin-embedded specimens. Applied Immmunohistochem 1:31–38, 1993

    Google Scholar 

  29. Marley E, Frost A, Tabbara S: The significance and reproducibility of microvessel quantitation in infiltrating lobular carcinoma of the breast. Ann Meeting Abs Internat Acad Pathol, 1995

  30. Tan LK, Lesser ML, Arroyo CD, Rosen PP: Intratumoral microvessel density and prognosis in T2N0M0 breast carcinoma. Ann Meeting Abs Internat Acad Pathol, 1995

  31. Costello P, McCann A, Carney D, Dervan PA: Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26:1181–1184, 1995

    PubMed  Google Scholar 

  32. Goulding H, Nik Abdoul Rahid NF, Robertson JF, Bell JA, Elston CW, Blamey RW, Ellis IO: Assessment of angiogenesis in breast carcinoma: An important factor in prognosis? Hum Pathol 26:1196–1200, 1995

    PubMed  Google Scholar 

  33. Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ: Comparison of different immunohistochemical methods in the assessment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 8:745–752, 1995

    PubMed  Google Scholar 

  34. Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Caffo O, Leonardi E, Mauri F, Bevilacqua P, Palma P: Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computeraided image analysis system. Appl Immunohistochem 3:75–84, 1995

    Google Scholar 

  35. Monschke F, Muller WU, Winkler U, Streffer C: Cell proliferation and vascularization in human breast carcinomas. Int J Cancer 49:812–815, 1991

    PubMed  Google Scholar 

  36. Vartanian RK, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvessel density (tumour angiogenesis) and tumour cell proliferation in breast carcinoma. Amer J Pathol 144:1188–1194, 1994

    Google Scholar 

  37. McGurrin JF, Doria MI, Dawson PJ, Karrison T, Stein HO, Franklin WA: Assessment of tumour cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 59:1744–1750, 1987

    PubMed  Google Scholar 

  38. Sterns EE, Zee B, SenGupta S, Saunders F: Thermography: Its relation to pathologic characteristics, vascularity, proliferation rate and survival in invasive ductal carcinoma of the breast. Cancer (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sterns, E.E., SenGupta, S., Saunders, F. et al. Vascularity demonstrated by doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast. Breast Cancer Res Tr 40, 197–203 (1996). https://doi.org/10.1007/BF01806215

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806215

Key words

Navigation